TY  - GEN
AU  - Chen,Y-H
AU  - Chen,S-N
AU  - Lien,R-I
AU  - Shih,C-P
AU  - Chao,A-N
AU  - Chen,K-J
AU  - Hwang,Y-S
AU  - Wang,N-K
AU  - Chen,Y-P
AU  - Lee,K-H
AU  - Chuang,C-C
AU  - Chen,T-L
AU  - Lai,C-C
AU  - Wu,W-C
TI  - Refractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomes
SN  - 1476-5454
PY  - 2015///0401
KW  - Angiogenesis Inhibitors
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - Axial Length, Eye
KW  - pathology
KW  - Bevacizumab
KW  - Child, Preschool
KW  - Combined Modality Therapy
KW  - Emmetropia
KW  - physiology
KW  - Female
KW  - Follow-Up Studies
KW  - Gestational Age
KW  - Humans
KW  - Infant, Very Low Birth Weight
KW  - Intravitreal Injections
KW  - Laser Coagulation
KW  - Male
KW  - Myopia
KW  - epidemiology
KW  - Prevalence
KW  - Refraction, Ocular
KW  - Retinopathy of Prematurity
KW  - drug therapy
KW  - Retrospective Studies
KW  - Vascular Endothelial Growth Factor A
KW  - antagonists & inhibitors
KW  - Visual Acuity
KW  - Vitrectomy
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study
UR  - https://doi.org/10.1038/eye.2014.172
ER  -